Skip to main content

Corporate News tagged:

3D cell culture

REPROCELL Corporate News

Prof Stefan Przyborski to give Keynote Address at this year’s SMi 3D Cell Culture Conference

13 February 2020

Dates: 19-20 February 2020 Venue: Copthorne Tara, London, United Kingdom Website: https://www.smi-online.co.uk/pharmaceuticals/uk/3D-Cell-Culture REPROCELL Europe’s CSO Professor Stefan Przyborski will giving the keynote address on 3D cell ...

REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018

24 January 2018

The SMi Group’s conference on 3D Cell Culture will be held on 21-22 February 2018.The venue is the Copthorne Tara Hotel in Kensington, London, UK. Find out more at www.3d-CellCulture.com REPROCELL Europe’s CSO Professor Stefan Przyborski wi...

Formation of human tissue to improve drug testing and reduce animal research

19 January 2018

REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, was in Durham University (UK) News. Developed at the university by Professor Stefan Prsyborski, Alvetex was first commercialised by the spin-out company Re...

Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination

07 February 2017

Scotland’s Life Sciences Dinner was held on 2nd February 2017 at the National Museum of Scotland. The event was attended by CEO and Chairman of REPROCELL Inc, Dr Chikafumi Yokoyama, as well as senior management members of REPROCELL Europe L...

Prof Stefan Przyborski to chair the SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb)

13 January 2017

The SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb) will be chaired by REPROCELL Europe’s chief scientific officer (CSO), Professor Stefan Przyborski. He will also be giving the first lecture in the conference. The SMi Group is a hi...

REPROCELL Europe wins CV Technology Innovator Awards 2016 for Alvetex

16 September 2016

REPROCELL Europe has won the Corporate Vision Technology Innovation Award 2016 for Alvetex technology for 3D cell culture. The following is CV Magazine’s interview with REPROCELL Europe’s CSO Professor Stefan Przyborski. MOST RENOWNED FOR I...

Prof Stefan Przyborski speaking at BBS 2016 Biennial Meeting

06 July 2016

ReproCELL Europe Ltd’s Chief Scientific Officer Prof Stefan Przyborski is giving a public lecture on “Scaffold Cell Culture Technology for Generation of In Vivo-like Tissue Models” at the British Biophysical Society 2016 Biennial Meeting 6t...

REPROCELL Europe’s (formerly Reinnervate’s) CSO Prof Stefan Przyborski to give an Alvetex Seminar at the University of Oxford, 24 May 2016

20 May 2016

Professor Stefan Przyborski, Chief Scientific Officer of REPROCELL Europe (formerly Reinnervate), is to give a seminar on Alvetex next week, 24th May 2016. Venue: Large Lecture Theatre Le Gros Clark Building Department of Physiology, Anatom...

Reinnervate Ltd wins Corporate Vision’s 2015 Technology Innovator Award for Alvetex

22 March 2016

We are pleased to announce that Reinnervate Ltd has been awarded Corporate Vision’s 2015 Technology Innovator Award for Alvetex 3D cell culture. Alvetex has been awarded the title, “Most Advanced 3D Cell Technology.” The awards have been an...

Alvetex in Space

14 January 2016

While the first British ESA astronaut Tim Peake is currently on the International Space Station (ISS) and is about to make his first spacewalk, now is a good time to mention again that Reinnervate’s flagship product, Alvetex® Scaffold, has ...

Publication of Paper on “3D culture model construction of mouse neurons” in Neuroscience Letters

18 November 2015

Notice concerning the publication of a paper concerning “3D culture model construction of mouse neurons” from a company in our group in the international neuroscience journal ‘Neuroscience Letters’ Company: REPROCELL,Inc. (JASDAQ Company co...

REPROCELL announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics” by REPROCELL and others

19 October 2015

Company: REPROCELL, Inc. (JASDAQ Company code: 4978) Representative: Chikafumi Yokoyama, PhD Contact: info-emea@reprocell.com We are pleased to announce that a research report on “3D Skin Model Construction,” submitted by our corporate grou...

Alvetex® 3D cell culture platform reaches new heights with project aboard the International Space Station (ISS).

20 April 2015

Sedgefield, UK. April 2015 – Market leading 3D cell culture company Reinnervate Ltd, part of the ReproCELL group, today announced that a rocket carrying its Alvetex® Scaffold technology blasted into Space this week. Alvetex will be used in ...

Alvetex Scaffold 384 well plates used in an Oncology HTS program by AstraZeneca

08 October 2014

Scientists at AstraZeneca in the UK have compared the activity of a diverse compound set in 2D and 3D cell cultures using Alvetex® Scaffold 384 well plates in an automated Oncology HTS (High Throughput Screening) setting. AstraZeneca report...

REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)

09 September 2014

YOKOHAMA, Japan — REPROCELL (JASDAQ:4978) announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. This acquisition allows the REPROCELL Group to expand the product lineups of its iPS Cell Business and establish technical...

Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)

05 August 2014

Location: REPROCELL Inc. (Yokohama, Japan) Date: August 5, 2014 The Japanese regenerative medicine company REPROCELL Inc. has announced the acquisition of Reinnervate Ltd. (UK), one of the leading companies in the field of 3D cell culture. ...

Launch of Reinnervate Perfusion System for 3D cell culture

05 February 2014

Reinnervate today announced the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media. This product allows scientists to create cell based models that are another step closer to th...

Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture

04 November 2013

Sedgefield, UK. November 2013 – 3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO’s to offer 3D tumour cell screening services. The CROs, Oncotest GmbH (Freiburg, Germany) and SBH Sciences (...

Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies

19 September 2013

Sedgefield, UK. September 2013 – Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services...

Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013

22 August 2013

Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course, which will be held on 7-8 November 2013 at their new premises in the Sci-Tech Daresbury Innovation Centre, UK. As part o...